Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M McShane

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarker Validation: Context and ComplexitiesLisa M McShane
BMC Medicine|May 31, 2012
Statistical challenges in the development and evaluation of marker-based clinical testsLisa M McShane
JNCI Cancer Spectrum|July 31, 2019
Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical TrialsLisa M McShane, Malcolm A Smith
Journal of Biopharmaceutical Statistics|August 26, 2016
Issues in developing multivariable molecular signatures for guiding clinical care decisionsMichael C Sachs, Lisa M McShane
Blood|December 17, 2016
Measure for measure: minimal residual disease in CLLRichard F Little, Lisa M McShane
Journal of the National Cancer Institute|November 8, 2024
Evaluating clinical utility of comprehensive genomic profiling-challenges and opportunitiesLisa M McShane, Lyndsay N Harris
Statistics in Medicine|May 1, 2022
Sample size methods for evaluation of predictive biomarkersKevin K Dobbin, Lisa M McShane
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F Hayes
Clinical Trials (London, England)|September 4, 2013
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utilityLisa M McShane, Mei-Yin C Polley
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 7, 2002
A paradigm for class prediction using gene expression profilesMichael D Radmacher, Lisa M McShane, Richard Simon
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarker Validation: Context and ComplexitiesLisa M McShane
BMC Medicine|May 31, 2012
Statistical challenges in the development and evaluation of marker-based clinical testsLisa M McShane
JNCI Cancer Spectrum|July 31, 2019
Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical TrialsLisa M McShane, Malcolm A Smith
Journal of Biopharmaceutical Statistics|August 26, 2016
Issues in developing multivariable molecular signatures for guiding clinical care decisionsMichael C Sachs, Lisa M McShane
Blood|December 17, 2016
Measure for measure: minimal residual disease in CLLRichard F Little, Lisa M McShane
Journal of the National Cancer Institute|November 8, 2024
Evaluating clinical utility of comprehensive genomic profiling-challenges and opportunitiesLisa M McShane, Lyndsay N Harris
Statistics in Medicine|May 1, 2022
Sample size methods for evaluation of predictive biomarkersKevin K Dobbin, Lisa M McShane
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F Hayes
Clinical Trials (London, England)|September 4, 2013
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utilityLisa M McShane, Mei-Yin C Polley
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 7, 2002
A paradigm for class prediction using gene expression profilesMichael D Radmacher, Lisa M McShane, Richard Simon
Pageof 16